Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs HCW Biologics Inc. (HCWB)

Biorestorative Therapies, Inc. and HCW Biologics Inc. are both Biotechnology companies. HCW Biologics Inc. is the larger, with a market value of $2.3M against $2.1M — 1.1× the size. HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against −8.47%. HCW Biologics Inc. has the higher net margin (−329.4% vs −3,089.3%) and the lower return on invested capital (−36.2% vs 0.00%). Across the 17 metrics below, HCW Biologics Inc. leads on 11 and Biorestorative Therapies, Inc. on 6.

Valuation

Metric BRTX HCWB Biotechnology median
P/E n/m n/m 10.60
P/S 3.67 0.20 9.40
P/B 0.43 0.18 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.15 n/m 0.66
EV/Sales (5.84) 1.12 9.02
Earnings yield (1,445.95%) (2,786.94%) (32.88%)
Free cash flow yield (999.27%) (915.31%) (23.13%)

Profitability

Metric BRTX HCWB Biotechnology median
Gross margin 92.09% 95.91% 68.51%
Operating margin (3,974.66%) (114.02%) 0.00%
Net margin (3,089.30%) (329.38%) 0.00%
Free cash flow margin (3,302.04%) (180.57%) 0.00%
Return on equity (241.50%) (600.32%) (51.96%)
Return on assets (147.75%) (79.52%) (46.06%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric BRTX HCWB Biotechnology median
Revenue growth (TTM) (8.47%) 706.96% 6.76%
EPS growth (last fiscal year) (36.21%) 65.49% 29.88%
Revenue growth, 5-year CAGR 36.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRTX HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 2.35 0.06 4.97
Net debt to EBITDA 0.19 (0.40) 1.01

Dividend

Metric BRTX HCWB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BRTX HCWB Biotechnology median
Market cap 2.09m 2.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack